Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone

Diabetes Obes Metab. 2026 Jul 28. doi: 10.1111/dom.71082. Online ahead of print.ABSTRACTAIMS: To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide,

S Sungho Bea

Sleep-Related and Chronobiology Traits and Health-Related Phenotypes: A Phenome-Wide Mendelian Randomisation Study

J Sleep Res. 2026 Jul 28:e70411. doi: 10.1111/jsr.70411. Online ahead of print.ABSTRACTSleep-related and chronotype traits have been shown to impact health in observational studies. To identify whether these associations are potentially causal, we conducted phenome-wide Mendelian randomisation analy

M Marta H Hernandez

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

Circ Arrhythm Electrophysiol. 2026 Jul 28:e014785. doi: 10.1161/CIRCEP.125.014785. Online ahead of print.ABSTRACTBACKGROUND: Recent meta-analyses of randomized controlled trials have raised concerns that treatment with omega-3 fatty acids may increase the risk of atrial fibrillation (AF). However, t

N Nada R Abuknesha

A Multitask Deep Learning Model for Pediatric Echocardiography Analysis

Circulation. 2026 Jul 28. doi: 10.1161/CIRCULATIONAHA.126.080619. Online ahead of print.ABSTRACTBACKGROUND: Congenital heart defects afflict ≈1% of all births worldwide. Although deep learning has shown significant promise in automating and improving adult echocardiography analysis, existing pediatr

J Joseph Cho

Lp(a) in chronic kidney disease: state of the art and management perspectives

J Nephrol. 2026 Jul 28:aajag084. doi: 10.1093/joneph/aajag084. Online ahead of print.ABSTRACTPatients with chronic kidney disease (CKD) exhibit a higher cardiovascular risk compared to the general population, due to CKD itself and its associated metabolic disorders, such as dyslipidemia. While stati

L Leonardo Spatola

POSS-PEG-NHS and GSH Cocrosslink DPAV to Prepare Anticalcification Bioprosthetic Scaffold With Enhanced Reendothelization, Anti-inflammation, and Anti-ROS

Adv Healthc Mater. 2026 Jul 28:e71407. doi: 10.1002/adhm.71407. Online ahead of print.ABSTRACTThe morbidity and mortality associated with heart valve disease (HVD) are progressively increasing, making it a leading cause of the global cardiovascular disease burden. The most effective current treatmen

Y Yuqing Zhang

Mitochondrial Dysfunction at the Crossroads of Necroptosis: Mechanisms, Molecular Mediators, and Therapeutic Opportunities

J Cell Mol Med. 2026 Jul;30(14):e71252. doi: 10.1111/jcmm.71252.ABSTRACTThe conceptual landscape of cell death has evolved beyond the traditional dichotomy of apoptosis and necrosis to encompass diverse regulated pathways including necroptosis, autophagy, ferroptosis, and pyroptosis. Necroptosis, a

F Fengxin Wang

Bibliometric Trends in Inflammasome-Driven Pyroptosis and Cardiovascular Disease

J Inflamm Res. 2026 Jul 23;19:609598. doi: 10.2147/JIR.S609598. eCollection 2026.ABSTRACTBACKGROUND AND PURPOSE: This bibliometric study provides the first comprehensive synthesis of inflammasome‑driven pyroptosis research in cardiovascular disease (CVD), systematically mapping its evolution. Pyropt

Y Yupei Tan

Construction and application of a smart hospital platform-based VTE risk management system

Front Public Health. 2026 Jul 13;14:1876826. doi: 10.3389/fpubh.2026.1876826. eCollection 2026.ABSTRACTOBJECTIVE: Venous thromboembolism (VTE) ranks as the third most prevalent cardiovascular disease after acute myocardial infarction and stroke, posing a significant risk to patient safety. Clinical

C Chengye Xu

Ultra-processed food exposure and health outcomes: Current evidence, controversies, and future perspectives

EXCLI J. 2026 Jul 9;25:1037-1069. doi: 10.17179/excli2026-9423. eCollection 2026.ABSTRACTUltra-processed food (UPF) exposure has increased markedly worldwide and is now a major contributor to total energy intake in many countries. Evidence from large prospective cohort studies suggests that higher U

M Monica Dinu

Embedding structural and social determinants of cardiovascular health into medical education: a systematic review of pedagogical frameworks

Front Med (Lausanne). 2026 Jul 13;13:1860983. doi: 10.3389/fmed.2026.1860983. eCollection 2026.ABSTRACTBACKGROUND: Cardiovascular disease remains the leading cause of preventable death globally, yet its burden is unequally distributed across social and structural lines. Given its unique clinical and

O Omar Dabash

Cumulative triglyceride-glucose-body mass index exposure and cardiovascular disease risk: findings from the Kailuan study

Front Cardiovasc Med. 2026 Jul 13;13:1670562. doi: 10.3389/fcvm.2026.1670562. eCollection 2026.ABSTRACTBACKGROUND: The relationship between cumulative triglyceride-glucose-body mass index (TyG-BMI) exposure and the risk of cardiovascular disease (CVD) has been unclear. This study investigated the as

P Peng Fu

The detection of cardiovascular biomarkers in dermal interstitial fluid - a step to real-time monitoring

Front Cardiovasc Med. 2026 Jul 13;13:1724051. doi: 10.3389/fcvm.2026.1724051. eCollection 2026.ABSTRACTCardiovascular biomarkers are central to the diagnosis and management of a range of acute and chronic disease states, yet current approaches remain dependent on episodic venous blood sampling. Derm

Y Yousaf Bhatti

MIAT: An important long non-coding RNA regulating cardiovascular and cerebrovascular diseases

Front Cardiovasc Med. 2026 Jul 13;13:1791657. doi: 10.3389/fcvm.2026.1791657. eCollection 2026.ABSTRACTCardiovascular and cerebrovascular diseases remain the leading cause of death worldwide. Myocardial infarction-associated transcript (MIAT), a type of long non-coding RNA, has been reported to exer

Y Yuxin Pan

Integrated management of atrial fibrillation and comorbidities in the community: a generalist-specialist collaborative RCT and subgroup analysis

Front Cardiovasc Med. 2026 Jul 13;13:1840644. doi: 10.3389/fcvm.2026.1840644. eCollection 2026.ABSTRACTOBJECTIVE: To develop, implement, and evaluate a community-based, patient-centered integrated care model for atrial fibrillation (AF) characterized by generalist-specialist collaboration and cardio

D Dai Huimin

Precision cardiovascular medicine: global imperative for equity through innovation

Front Cardiovasc Med. 2026 Jul 13;13:1835607. doi: 10.3389/fcvm.2026.1835607. eCollection 2026.ABSTRACTCardiovascular disease remains the world's leading cause of death, with a disproportionate burden falling on low- and middle-income countries. Emerging precision medicine approaches, such as artifi

J Jose R Medina-Inojosa

Immune checkpoint inhibitor-driven smooth muscle cell phenotypic modulation: a potential contributor to atherosclerotic risk associated with these therapies

Front Cardiovasc Med. 2026 Jul 13;13:1789821. doi: 10.3389/fcvm.2026.1789821. eCollection 2026.ABSTRACTImmune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but are associated with increased atherosclerotic cardiovascular disease (ASCVD) risk independent of plasma cholesterol levels

A Abhijnan Chattopadhyay

Multiparametric cardiovascular magnetic resonance for differentiating cardiac masses: clinical impact from a case series

Eur Heart J Case Rep. 2026 Jul 15;10(7):ytag532. doi: 10.1093/ehjcr/ytag532. eCollection 2026 Jul.ABSTRACTBACKGROUND: Cardiac masses represent a rare but clinically significant diagnostic entity. Morphological assessment alone is often insufficient for definitive diagnosis. Cardiovascular magnetic r

M Mauricio Garcia-Cardenas

Pleuroparenchymal fibroelastosis-like findings identify an idiopathic pulmonary fibrosis subgroup with shortened telomeres and poor prognosis

ERJ Open Res. 2026 Jul 27;12(4):01619-2025. doi: 10.1183/23120541.01619-2025. eCollection 2026 Jul.ABSTRACTBACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease (ILD) with poor prognosis. Radiological pleuroparenchymal fibroelastosis (PPFE)-like finding

R Ryota Otoshi

Two-Year Clinical Outcomes in Patients With Coronary Bifurcation Lesions: Results From the Onyx ONE Clear Study

J Soc Cardiovasc Angiogr Interv. 2026 May 12;5(6):105338. doi: 10.1016/j.jscai.2026.105338. eCollection 2026 Jun.ABSTRACTBACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) for high bleeding risk (HBR) patients undergoing percutaneous coronary intervention (PCI) can vary based on in

C Christopher Garnett

Raptor-Assisted Retrieval of a Radiolucent Perforating Intracardiac Foreign Body

No abstractJ Soc Cardiovasc Angiogr Interv. 2026 Apr 30;5(6):105341. doi: 10.1016/j.jscai.2026.105341. eCollection 2026 Jun.NO ABSTRACTPMID:42516854 | PMC:PMC13404052 | DOI:10.1016/j.jscai.2026.105341

J James F Howick V

Cardiovascular Impact of Endovascular Revascularization in Chronic Limb-Threatening Ischemia Versus Claudication: A Contemporary Real-World Analysis

J Soc Cardiovasc Angiogr Interv. 2026 Apr 23;5(6):105372. doi: 10.1016/j.jscai.2026.105372. eCollection 2026 Jun.ABSTRACTBACKGROUND: Chronic limb-threatening ischemia (CLTI) represents the most severe form of peripheral artery disease, yet long-term cardiovascular outcomes after endovascular revascu

S Sultana Jahan

Evaluation of a Novel Antegrade-to-Retrograde Femoral Sheath Conversion System: A Preclinical, Cadaveric Study

J Soc Cardiovasc Angiogr Interv. 2026 Apr 30;5(6):105336. doi: 10.1016/j.jscai.2026.105336. eCollection 2026 Jun.ABSTRACTBACKGROUND: Peripheral arterial disease often affects the lower extremities, is frequently bilateral, and typically involves multiple leg segments. Symptomatic disease is usually

R Ramakrishnan Ranganath

Association of Periprocedural GLP-1 Receptor Agonist Therapy With 1-Year Major Adverse Cardiovascular Events After Carotid Artery Stenting: A Propensity-Matched Analysis

J Soc Cardiovasc Angiogr Interv. 2026 Apr 24;5(6):105387. doi: 10.1016/j.jscai.2026.105387. eCollection 2026 Jun.ABSTRACTBACKGROUND: Major adverse cardiovascular events (MACE) following carotid artery stenting (CAS) remain clinically significant. Pharmacological strategies to reduce postprocedural c

A Abdullah Ghuman